DENTSPLY SIRONA Inc (NASDAQ:XRAY) SVP Maureen J. Macinnis sold 15,000 shares of the company’s stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $56.06, for a total transaction of $840,900.00. Following the completion of the transaction, the senior vice president now owns 25,360 shares in the company, valued at $1,421,681.60. The sale was disclosed in a filing with the SEC, which is available through this link.

Shares of XRAY opened at $56.90 on Thursday. DENTSPLY SIRONA Inc has a fifty-two week low of $33.93 and a fifty-two week high of $57.71. The company has a market capitalization of $13.31 billion, a PE ratio of 28.31, a price-to-earnings-growth ratio of 2.08 and a beta of 0.95. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.06 and a quick ratio of 1.35.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.10. DENTSPLY SIRONA had a negative net margin of 26.48% and a positive return on equity of 8.99%. The firm had revenue of $946.20 million during the quarter, compared to analysts’ expectations of $925.13 million. During the same quarter in the prior year, the company earned $0.45 EPS. The company’s revenue was down 1.0% compared to the same quarter last year. As a group, equities analysts expect that DENTSPLY SIRONA Inc will post 2.35 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, July 12th. Investors of record on Friday, June 28th will be given a dividend of $0.0875 per share. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.35 dividend on an annualized basis and a yield of 0.62%. DENTSPLY SIRONA’s dividend payout ratio is presently 17.41%.

A number of large investors have recently bought and sold shares of the stock. Allstate Corp acquired a new position in DENTSPLY SIRONA during the 1st quarter valued at approximately $211,000. Cleararc Capital Inc. acquired a new position in DENTSPLY SIRONA during the 1st quarter valued at approximately $268,000. Horizon Investments LLC acquired a new position in DENTSPLY SIRONA during the 1st quarter valued at approximately $297,000. FMR LLC increased its stake in DENTSPLY SIRONA by 32.7% during the 1st quarter. FMR LLC now owns 1,616,546 shares of the medical instruments supplier’s stock valued at $80,164,000 after purchasing an additional 398,372 shares in the last quarter. Finally, BlueMountain Capital Management LLC acquired a new position in DENTSPLY SIRONA during the 1st quarter valued at approximately $5,197,000. 91.68% of the stock is owned by institutional investors.

A number of equities analysts have commented on XRAY shares. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $55.00 target price on the stock in a research note on Saturday, March 9th. Bank of America started coverage on shares of DENTSPLY SIRONA in a research note on Monday, March 18th. They issued a “buy” rating and a $57.00 target price on the stock. BidaskClub downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 23rd. ValuEngine raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Finally, HC Wainwright set a $49.00 price target on shares of DENTSPLY SIRONA and gave the stock a “hold” rating in a research report on Friday, April 5th. Eight analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. DENTSPLY SIRONA has a consensus rating of “Buy” and a consensus target price of $53.62.

ILLEGAL ACTIVITY WARNING: “Insider Selling: DENTSPLY SIRONA Inc (NASDAQ:XRAY) SVP Sells 15,000 Shares of Stock” was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://theolympiareport.com/2019/06/13/insider-selling-dentsply-sirona-inc-nasdaqxray-svp-sells-15000-shares-of-stock.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Read More: How much money do you need to begin day trading?

Insider Buying and Selling by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.